Clinical Trial Update: Pilot Efficacy Study of PI-88 With Docetaxel to Treat Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 pilot efficacy study evaluating PI-88 in combination with docetaxel for prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• PI-88

Snippet

Sponsor: Progen Pharmaceuticals | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED